Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rohto Pharmaceutical CoTSE:4527 -1.72%92 Dividend Yield % is 1.86% as of Jul. 21, 2026, which is 121% above its 10-year median of 0.84. GuruFocus rates TSE:4527 with a GF Score™ of 92/100 and a GF Value™ of 円3,477.35 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,171 Consumer Packaged Goods companies, Rohto Pharmaceutical Co ranks worse than 67.81% on this metric.
As of today (2026-07-21), the Trailing Annual Dividend Yield of Rohto Pharmaceutical Co is 1.86%.
Good Sign:
Rohto Pharmaceutical Co Ltd stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for Rohto Pharmaceutical Co's Dividend Yield % or its related term are showing as below:
TSE:4527'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.54 Med: 0.84 Max: 1.98
Current: 1.86
During the past 13 years, the highest Dividend Yield of Rohto Pharmaceutical Co was 1.98%. The lowest was 0.54%. And the median was 0.84%.
TSE:4527's Dividend Yield % is ranked worse than 67.81% of 1171
companies
in the Consumer Packaged Goods industry
Industry Median: 2.86
vs TSE:4527: 1.86
During the past 12 months, Rohto Pharmaceutical Co's average Dividends Per Share Growth Rate was 27.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 27.90% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 27.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 16.60% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Rohto Pharmaceutical Co was 41.50% per year. The lowest was 4.80% per year. And the median was 7.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Rohto Pharmaceutical Co (TSE:4527) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4527 vs PG, CL, KVUE: Dividend Yield % Comparison
For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rohto Pharmaceutical Co Dividend Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Rohto Pharmaceutical Co's Dividend Yield % falls into.
Rohto Pharmaceutical Co Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Rohto Pharmaceutical Co Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
JPY 25.000000
2026-03-30
2026-03-31
2026-06-08
Cash Dividend
semi-annually
JPY:JPY 1.000000
JPY 21.000000
2025-09-29
2025-09-30
2025-12-04
Cash Dividend
semi-annually
JPY:JPY 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rohto Pharmaceutical Co (TSE:4527) has a Dividend Yield % of 1.86% as of Jul. 21, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Rohto Pharmaceutical Co and its competitors. This is 121% above median its historical median of 0.84. Over the past decade, Rohto Pharmaceutical Co's Dividend Yield % has ranged from 0.54 to 1.98. According to the industry distribution chart, Rohto Pharmaceutical Co ranks #794 out of 1171 companies in the Consumer Packaged Goods industry, placing it in the top 67.8%.
Is Rohto Pharmaceutical Co's Dividend Yield % too high?
Rohto Pharmaceutical Co's current Dividend Yield % of 1.86% is 121% above median its 10-year median of 0.84. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 1.98. The Consumer Packaged Goods industry median Dividend Yield % is 2.86. Rohto Pharmaceutical Co's value of 1.86% is 35% below this industry median. Based on the distribution chart, Rohto Pharmaceutical Co ranks #794 out of 1171 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Rohto Pharmaceutical Co has a GF Score™ of 92/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's Dividend Yield % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Rohto Pharmaceutical Co ranks #794 out of 1171 companies for Dividend Yield %. This places Rohto Pharmaceutical Co in the lower half of its industry. The industry median Dividend Yield % is 2.86. Rohto Pharmaceutical Co's value of 1.86% is 35% below this benchmark. Historically, Rohto Pharmaceutical Co's own Dividend Yield % has ranged from 0.54 to 1.98 over the past decade. While the company's 10-year median is 0.84 vs. the industry median of 2.86, Rohto Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Consumer Packaged Goods company?
The median Dividend Yield % among Consumer Packaged Goods companies is 2.86, based on 1,171 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rohto Pharmaceutical Co's current Dividend Yield % of 1.86% is 35% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Rohto Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median Dividend Yield % is 2.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rohto Pharmaceutical Co's current Dividend Yield % is 1.86%, which is 121% above median its own 10-year median of 0.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co (TSE:4527) is currently considered Significantly Undervalued. The stock's GF Value™ is 円3,477.35, compared to a current price of 円2,435.00 — trading 30% below its estimated fair value. The current Dividend Yield % is 1.86%, which is 121% above median its 10-year median of 0.84 and 35% below the Consumer Packaged Goods industry median of 2.86. Rohto Pharmaceutical Co's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Rohto Pharmaceutical Co (TSE:4527), the current Dividend Yield % is 1.86% as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rohto Pharmaceutical Co (TSE:4527) Overvalued in 2026?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円2,435.00 is trading 30% below its estimated GF Value™ of 円3,477.35.
GuruFocus considers Rohto Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for TSE:4527:
Dividend Yield %: 1.86% (121% above median its 10-year median of 0.84)
GF Value™: 円3,477.35 vs. price of 円2,435.00 (30% below fair value)
Industry Position: 35% below the Consumer Packaged Goods median (#794 of 1171)
No single metric tells the full story. See the TSE:4527 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
92GF Score
Get the complete analysis for TSE:4527
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4527 has been successfully added to your 
